PZ Cormay Past Earnings Performance

Past criteria checks 0/6

PZ Cormay has been growing earnings at an average annual rate of 53.6%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 1.8% per year.

Key information

53.6%

Earnings growth rate

54.0%

EPS growth rate

Medical Equipment Industry Growth25.3%
Revenue growth rate1.8%
Return on equity-6.5%
Net Margin-6.4%
Next Earnings Update20 Sep 2024

Recent past performance updates

Recent updates

Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Sep 08
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

Feb 27
There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Sep 15
PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Revenue & Expenses Breakdown

How PZ Cormay makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:CRM Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2457-4174
31 Dec 2354-2174
30 Sep 2384-5354
30 Jun 2387-1364
31 Mar 2385-3364
31 Dec 2252-4173
30 Sep 2288-4344
30 Jun 2287-7344
31 Mar 2286-2323
31 Dec 21852313
30 Sep 2181-4302
30 Jun 2175-3291
31 Mar 2168-4281
31 Dec 2065-13290
30 Sep 2063-46310
30 Jun 2067-46320
31 Mar 2069-50330
31 Dec 1968-41330
30 Sep 1970-27320
30 Jun 1966-25320
31 Mar 1968-22330
31 Dec 1870-25330
30 Sep 1871-1330
30 Jun 1871-1330
31 Mar 1874-1340
31 Dec 1778-2350
30 Sep 1776-13360
30 Jun 1779-14360
31 Mar 1781-13360
31 Dec 1682-11360
30 Sep 1675-3320
30 Jun 1668-3270
31 Mar 1655-7250
31 Dec 1545-25200
30 Sep 1557-56300
30 Jun 1567-55362
31 Mar 1584-60402
31 Dec 1499-42462
30 Sep 14104-10397
30 Jun 14104-9376
31 Mar 141021345
31 Dec 131012355
30 Sep 13995360
30 Jun 1310411360

Quality Earnings: CRM is currently unprofitable.

Growing Profit Margin: CRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CRM is unprofitable, but has reduced losses over the past 5 years at a rate of 53.6% per year.

Accelerating Growth: Unable to compare CRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.9%).


Return on Equity

High ROE: CRM has a negative Return on Equity (-6.54%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.